Nephros(NEPH)
$3.07-0.08 (-2.54%)
NEPH
Nephros financials statements
$3.07
At close:-0.08 (-2.54%)
Want to see NEPH full AI Analyst Report?
Nephros (NEPH) Ratios
94 Followers
Nephros Ratios
NEPH's free cash flow for Q3 2026 was $-150.00K. For the 2026 fiscal year, NEPH's free cash flow was increased by $0.00 and operating cash flow was $-150.00K. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 4.06 | 5.31 | 3.98 | 5.85 | 5.70 |
| Quick Ratio | 2.89 | 3.64 | 2.81 | 3.62 | 3.84 |
| Cash Ratio | 1.95 | 2.41 | 2.04 | 2.57 | 2.92 |
| Solvency Ratio | 0.39 | 0.08 | -0.39 | -3.22 | -1.33 |
| Operating Cash Flow Ratio | 0.59 | -0.31 | 0.39 | -2.29 | -0.59 |
| Short-Term Operating Cash Flow Coverage | 4.21 | 0.00 | 0.00 | -45.55 | -5.71 |
| Net Current Asset Value | $ 7.78M | $ 5.67M | $ 4.90M | $ 6.14M | $ 10.73M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.08 | 0.13 | 0.15 | 0.10 | 0.06 |
| Debt-to-Equity Ratio | 0.10 | 0.16 | 0.22 | 0.20 | 0.09 |
| Debt-to-Capital Ratio | 0.09 | 0.14 | 0.18 | 0.16 | 0.08 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 |
| Financial Leverage Ratio | 1.34 | 1.31 | 1.42 | 1.97 | 1.51 |
| Debt Service Coverage Ratio | 3.40 | 212.00 | -679.50 | -40.51 | -8.62 |
| Interest Coverage Ratio | 1146.00 | 6.00 | -796.50 | -216.75 | -79.32 |
| Debt to Market Cap | 0.01 | 0.00 | 0.00 | 0.01 | 0.01 |
| Interest Debt Per Share | 0.10 | 0.13 | 0.18 | 0.11 | 0.10 |
| Net Debt to EBITDA | -3.22 | -10.35 | 1.82 | 0.69 | 2.40 |
| Profitability Margins | |||||
| Gross Profit Margin | 61.13% | 61.59% | 59.03% | 47.43% | 55.13% |
| EBIT Margin | 6.42% | 0.64% | -11.05% | -42.68% | -26.85% |
| EBITDA Margin | 7.16% | 1.60% | -9.54% | -36.95% | -24.38% |
| Operating Profit Margin | 6.10% | 0.04% | -11.19% | -43.46% | -31.83% |
| Pretax Profit Margin | 6.42% | 0.63% | -11.06% | -42.88% | -27.25% |
| Net Profit Margin | 6.35% | 0.52% | -11.06% | -74.01% | -40.20% |
| Continuous Operations Profit Margin | 6.35% | 0.52% | -11.06% | -42.88% | -27.25% |
| Net Income Per EBT | 99.00% | 83.15% | 100.00% | 172.60% | 147.52% |
| EBT Per EBIT | 105.24% | 1483.33% | 98.87% | 98.66% | 85.61% |
| Return on Assets (ROA) | 8.75% | 0.66% | -13.28% | -67.12% | -23.27% |
| Return on Equity (ROE) | 11.70% | 0.86% | -18.84% | -132.01% | -35.12% |
| Return on Capital Employed (ROCE) | 10.54% | 0.06% | -16.34% | -45.22% | -21.31% |
| Return on Invested Capital (ROIC) | 10.07% | 0.05% | -15.63% | -43.46% | -20.55% |
| Return on Tangible Assets | 9.50% | 0.75% | -15.07% | -78.41% | -25.85% |
| Earnings Yield | 2.31% | 0.48% | -4.38% | -61.80% | -6.95% |
| Efficiency Ratios | |||||
| Receivables Turnover | 7.78 | 7.95 | 9.52 | 7.76 | 6.23 |
| Payables Turnover | 7.99 | 8.38 | 6.68 | 7.09 | 3.44 |
| Inventory Turnover | 2.26 | 2.08 | 2.36 | 1.66 | 1.03 |
| Fixed Asset Turnover | 16.67 | 9.21 | 7.27 | 9.07 | 14.89 |
| Asset Turnover | 1.38 | 1.26 | 1.20 | 0.91 | 0.58 |
| Working Capital Turnover Ratio | 2.47 | 2.17 | 2.17 | 1.10 | 0.81 |
| Cash Conversion Cycle | 162.73 | 177.84 | 138.28 | 215.01 | 307.69 |
| Days of Sales Outstanding | 46.89 | 45.90 | 38.35 | 47.06 | 58.62 |
| Days of Inventory Outstanding | 161.51 | 175.49 | 154.56 | 219.46 | 355.29 |
| Days of Payables Outstanding | 45.67 | 43.55 | 54.63 | 51.51 | 106.22 |
| Operating Cycle | 208.41 | 221.39 | 192.91 | 266.52 | 413.91 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.16 | -0.05 | 0.08 | -0.31 | -0.14 |
| Free Cash Flow Per Share | 0.16 | -0.05 | 0.07 | -0.33 | -0.15 |
| Dividend Paid and CapEx Coverage Ratio | 0.00 | -8.95 | 11.03 | -23.61 | -39.36 |
| Capital Expenditure Coverage Ratio | 0.00 | -8.95 | 11.03 | -23.61 | -39.36 |
| Operating Cash Flow Coverage Ratio | 1.55 | -0.35 | 0.45 | -2.96 | -1.42 |
| Operating Cash Flow to Sales Ratio | 0.09 | -0.03 | 0.06 | -0.32 | -0.14 |
| Free Cash Flow Yield | 3.18% | -3.54% | 2.09% | -28.22% | -2.46% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 44.36 | 210.00 | -22.82 | -1.62 | -14.39 |
| Price-to-Sales (P/S) Ratio | 2.76 | 1.09 | 2.52 | 1.20 | 5.78 |
| Price-to-Book (P/B) Ratio | 5.08 | 1.80 | 4.30 | 2.14 | 5.05 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 31.48 | -28.29 | 47.79 | -3.54 | -40.68 |
| Price-to-Operating Cash Flow Ratio | 31.48 | -31.45 | 43.45 | -3.69 | -41.71 |
| Price-to-Earnings Growth (PEG) Ratio | 0.03 | -2.01 | 0.29 | -0.02 | 0.68 |
| Enterprise Value Multiple | 35.25 | 57.81 | -24.62 | -2.55 | -21.33 |
| Enterprise Value | 47.45M | 13.12M | 33.46M | 9.40M | 53.13M |
| EV to EBITDA | 35.25 | 57.81 | -24.62 | -2.55 | -21.33 |
| EV to Sales | 2.53 | 0.93 | 2.35 | 0.94 | 5.20 |
| EV to Free Cash Flow | 28.85 | -23.99 | 44.50 | -2.79 | -36.57 |
| EV to Operating Cash Flow | 28.85 | -26.67 | 40.47 | -2.91 | -37.50 |
| Tangible Book Value Per Share | 0.86 | 0.69 | 0.67 | 0.71 | 1.30 |
| Shareholders’ Equity Per Share | 0.96 | 0.82 | 0.80 | 0.54 | 1.17 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.01 | 0.17 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 1.77 | 1.35 | 1.37 | 0.97 | 1.02 |
| Net Income Per Share | 0.11 | 0.01 | -0.15 | -0.72 | -0.41 |
| Tax Burden | 0.99 | 0.83 | 1.00 | 1.73 | 1.48 |
| Interest Burden | 1.00 | 0.99 | 1.00 | 1.00 | 1.01 |
| Research & Development to Revenue | 0.07 | 0.06 | 0.06 | 0.13 | 0.15 |
| SG&A to Revenue | 0.48 | 0.54 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.02 | 0.01 | 0.07 | 0.10 | 0.12 |
| Income Quality | 1.38 | -6.65 | -0.53 | 0.71 | 0.37 |
Currency in USD
